Pure red cell aplasia among ABO mismatched hematopoietic stem cell transplant recipients: a 13-years retrospective study and literature review

Autor: Elisabetta Metafuni, Maria Teresa Busnego Barreto, Caterina Giovanna Valentini, Sabrina Giammarco, Maria Assunta Limongiello, Federica Sorà, Maria Bianchi, Giuseppina Massini, Nicola Piccirillo, Rossana Putzulu, Filippo Frioni, Andrea Bacigalupo, Luciana Teofili, Patrizia Chiusolo, Simona Sica

Publikováno v: Frontiers in Oncology, Vol 14 (2024)

BackgroundPure red cell aplasia (PRCA) is a possible complication after allogeneic hematopoietic stem cell transplantation (HSCT) with major ABO incompatibility. Patients experience delayed engraftment of the erythroid series, with prolonged transfus

Externí odkaz: https://doaj.org/article/b418add87c7640328f6d81f0518fcf71

Antigen-Specific Immunoadsorption With the Glycosorb® ABO Immunoadsorption System as a Novel Treatment Modality in Pure Red Cell Aplasia Following Major and Bidirectional ABO-Incompatible Allogeneic Hematopoietic Stem Cell Transplantation

Autor: Ammon Handisurya, Nina Worel, Werner Rabitsch, Marija Bojic, Sahra Pajenda, Roman Reindl-Schwaighofer, Wolfgang Winnicki, Andreas Vychytil, Hanna A. Knaus, Rainer Oberbauer, Kurt Derfler, Philipp Wohlfarth

Publikováno v: Frontiers in Medicine, Vol 7 (2020)

Pure red cell aplasia (PRCA) after ABO-incompatible allogeneic hematopoietic stem cell transplantation (HSCT) is caused by persisting host-derived isohemagglutinins directed against donor red blood cell (RBC) antigens. ABO antigen-specific immunoadso

Externí odkaz: https://doaj.org/article/38314e7bdc4b4128b4a7a5e8f12d04f1

Pure red cell aplasia after major or bidirectional ABO incompatible hematopoietic stem cell transplantation: to treat or not to treat, that is the question

Autor: Marco-Ayala J, Gómez-Seguí I, Sanz G, Solves P

Publikováno v: BONE MARROW TRANSPLANTATION
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname

Pure red cell aplasia (PRCA) is a complication related to major or bidirectional ABO mismatched hematopoietic stem cell transplantation. This disorder is characterized by anemia, reticulocytopenia, and the absence or virtual absence of erythroid prog

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::2d987047cce2929d5ef408a2e9f3be36
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=13606

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Hemolytic anemia following intravenous immunoglobulin therapy in patients treated for Kawasaki disease: a report of 4 cases

Autor: Berard Roberta, Whittemore Blair, Scuccimarri Rosie

Publikováno v: Pediatric Rheumatology Online Journal, Vol 10, Iss 1, p 10 (2012)

Abstract Background Hemolytic anemia is a rare but reported side effect of intravenous immunoglobulin (IVIG) therapy. The risk of significant hemolysis appears greater in those patients who receive high dose IVIG. The etiology is multifactorial but m

Externí odkaz: https://doaj.org/article/26400e88b20a457996f1b5449323278a